Institutional investors purchased a net $2.6 million shares of PTN during the quarter ended September 2015 and now own 26.23% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 1.4 Million shares of Palatin Technologies Inc